Metraipolis › archive › dc_3fbdce89d399

The Impact of Type 2 Diabetes in Parkinson's Disease — Europe PMC PMID:35699244

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35699244
DOI
10.1002/mds.29122
License (as archived)
solo-consultazione
Archived
2026-10-06T10:24:21.451Z
SHA-256 of the archived text
14c700adf1e4f6c7d57224acb6f5a3d2ae1f85746003651510db062feb876d56
Stable URL of this page
https://metraipolis.com/documento/dc_3fbdce89d399

How to cite

The Impact of Type 2 Diabetes in Parkinson's Disease — Europe PMC PMID:35699244 — Europe PMC (en), https://europepmc.org/article/MED/35699244 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3fbdce89d399 (Metraipolis archive dc_3fbdce89d399, sha256 14c700adf1e4f6c7d57224acb6f5a3d2ae1f85746003651510db062feb876d56)
BibTeX
@misc{dc3fbdce89d399,
  title = {The Impact of Type 2 Diabetes in Parkinson's Disease — Europe PMC PMID:35699244},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35699244},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3fbdce89d399; sha256 14c700adf1e4f6c7d57224acb6f5a3d2ae1f85746003651510db062feb876d56},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/35699244. Agents can read the archived copy with the MCP tool read_document.